...
首页> 外文期刊>BMC Pediatrics >School-age effects of the newborn individualized developmental care and assessment program for preterm infants with intrauterine growth restriction: preliminary findings
【24h】

School-age effects of the newborn individualized developmental care and assessment program for preterm infants with intrauterine growth restriction: preliminary findings

机译:新生儿个性化发育护理和评估计划对宫内发育受限早产儿的学龄影响:初步发现

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background The experience in the newborn intensive care nursery results in premature infants’ neurobehavioral and neurophysiological dysfunction and poorer brain structure. Preterms with severe intrauterine growth restriction are doubly jeopardized given their compromised brains. The Newborn Individualized Developmental Care and Assessment Program improved outcome at early school-age for preterms with appropriate intrauterine growth. It also showed effectiveness to nine months for preterms with intrauterine growth restriction. The current study tested effectiveness into school-age for preterms with intrauterine growth restriction regarding executive function (EF), electrophysiology (EEG) and neurostructure (MRI). Methods Twenty-three 9-year-old former growth-restricted preterms, randomized at birth to standard care (14 controls) or to the Newborn Individualized Developmental Care and Assessment Program (9 experimentals) were assessed with standardized measures of cognition, achievement, executive function, electroencephalography, and magnetic resonance imaging. The participating children were comparable to those lost to follow-up, and the controls to the experimentals, in terms of newborn background health and demographics. All outcome measures were corrected for mother’s intelligence. Analysis techniques included two-group analysis of variance and stepwise discriminate analysis for the outcome measures, Wilks’ lambda and jackknifed classification to ascertain two-group classification success per and across domains; canonical correlation analysis to explore relationships among neuropsychological, electrophysiological and neurostructural domains at school-age, and from the newborn period to school-age. Results Controls and experimentals were comparable in age at testing, anthropometric and health parameters, and in cognitive and achievement scores. Experimentals scored better in executive function, spectral coherence, and cerebellar volumes. Furthermore, executive function, spectral coherence and brain structural measures discriminated controls from experimentals. Executive function correlated with coherence and brain structure measures, and with newborn-period neurobehavioral assessment. Conclusion The intervention in the intensive care nursery improved executive function as well as spectral coherence between occipital and frontal as well as parietal regions. The experimentals’ cerebella were significantly larger than the controls’. These results, while preliminary, point to the possibility of long-term brain improvement even of intrauterine growth compromised preterms if individualized intervention begins with admission to the NICU and extends throughout transition home. Larger sample replications are required in order to confirm these results. Clinical trial registration The study is registered as a clinical trial. The trial registration number is NCT00914108.
机译:背景新生儿重症监护室的经验导致早产婴儿的神经行为和神经生理功能障碍,以及大脑结构较差。严重的宫内发育受限的早产儿由于大脑受损而受到双重危害。新生儿个体化发育护理和评估计划改善了早产儿子宫内适当生长的早产结局。对于宫内生长受限的早产儿,它也显示了长达9个月的有效性。本研究在学龄前对宫内发育受限的早产儿的执行功能(EF),电生理(EEG)和神经结构(MRI)进行了测试。方法采用标准化的认知,成就,执行力评估方法,对23名9岁的前生长受限早产儿进行随机分娩,分别接受标准护理(14名对照)或新生儿个性化发育护理和评估计划(9名实验者)。功能,脑电图和磁共振成像。从新生儿背景健康和人口统计学的角度来看,参与研究的儿童与那些因随访而失去的儿童以及实验的对照者相当。所有结果指标均已根据母亲的智力进行了更正。分析技术包括两组方差分析和针对结果度量的逐步判别分析,Wilks lambda和致密分类,以确定每个域和跨域的两组分类成功。进行规范相关分析,以探讨学龄儿童以及从新生儿到学龄期的神经心理学,电生理学和神经结构领域之间的关系。结果对照组和实验组在测试年龄,人体测量学和健康参数以及认知和成就评分方面均具有可比性。实验在执行功能,频谱相干性和小脑体积方面得分更高。此外,执行功能,频谱相干性和大脑结构测量将控制与实验区分开。执行功能与连贯性和大脑结构测量以及新生儿期神经行为评估相关。结论对重症监护室的干预改善了执行功能以及枕叶与额叶以及顶叶区域之间的光谱一致性。实验人员的小脑明显大于对照组。这些结果虽然是初步的,但指出如果个体化干预始于入院并进入整个过渡期,那么即使是宫内生长受损的早产儿,也可能长期改善大脑。为了确认这些结果,需要更大的样品重复量。临床试验注册该研究已注册为临床试验。试用注册号为NCT00914108。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号